ChengDu Sheng Nuo Biotec
688117
Nanjing Railway New Technology
301016
Tibet Duo Rui Pharmaceutical
301075
THEC
833509
Chengdu New Tianfu Culture Tourism Development
000558
CN Stock MarketDetailed Quotes
000532 Zhuhai Huajin Capital
- 15.67
- -0.08-0.51%
Trading Mar 31 09:37 CST
5.40BMarket Cap34.52P/E (TTM)
15.77High15.42Low14.26KlotVolume15.77Open15.75Pre Close22.21MTurnover0.42%Turnover Ratio34.52P/E (Static)344.71MShares20.1052wk High3.64P/B5.38BFloat Cap9.5152wk Low17.33Limit Up343.55MShs Float37.88Historical High14.18Limit Down2.22%Amplitude0.27Historical Low0.07Dividend TTM15.58Avg Price8.19KlotAsk0.41%Div YieldTTM100Lot Size4.62KlotBid
Zhuhai Huajin Capital Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 21.18%485.86M | 8.71%300.26M | 11.40%196.48M | 17.95%98.12M | -38.53%400.96M | -47.10%276.2M | -46.96%176.37M | -28.07%83.19M | 3.39%652.24M | 40.74%522.07M |
| Operating revenue | 21.18%485.86M | 8.71%300.26M | 11.40%196.48M | 17.95%98.12M | -38.53%400.96M | -47.10%276.2M | -46.96%176.37M | -28.07%83.19M | 3.39%652.24M | 40.74%522.07M |
| Other operating revenue | 17.00%8.9M | ---- | 47.75%4.58M | ---- | -22.52%7.6M | ---- | -40.17%3.1M | ---- | -5.18%9.81M | ---- |
| Total operating cost | -2.59%336.24M | 7.13%248.26M | 12.00%165.88M | 4.50%83.08M | -41.55%345.17M | -52.53%231.73M | -53.63%148.11M | -30.44%79.5M | 12.21%590.59M | 45.33%488.18M |
| Operating cost | 2.91%237.37M | 10.67%174.58M | 15.64%113.63M | 2.57%56.56M | -43.96%230.67M | -53.88%157.75M | -56.69%98.26M | -27.48%55.14M | 17.41%411.62M | 53.50%342.03M |
| Operating tax surcharges | 12.54%6.67M | 27.69%4.7M | 39.72%3.07M | 76.91%1.3M | -29.53%5.93M | 5.35%3.68M | -7.36%2.19M | -17.74%732.89K | 28.52%8.41M | -2.34%3.49M |
| Operating expense | 21.06%4.11M | 54.35%4.45M | 65.21%3.07M | 91.19%1.19M | -59.64%3.4M | -64.13%2.88M | -58.73%1.86M | -66.43%620.73K | -4.37%8.42M | 40.60%8.03M |
| Administration expense | -19.06%57.55M | 1.55%42.99M | 12.78%32.32M | 17.58%16.89M | -16.44%71.1M | -35.69%42.33M | -36.61%28.65M | -21.62%14.37M | 3.25%85.09M | 24.52%65.82M |
| Financial expense | -30.41%18.62M | -26.93%14.67M | -29.00%9.94M | -24.18%5.42M | -22.95%26.76M | -28.78%20.07M | -23.35%14M | -1.08%7.15M | 21.79%34.73M | 26.19%28.19M |
| -Interest expense (Financial expense) | -34.31%21.45M | -35.02%16.6M | -38.59%11.13M | -29.72%6M | -18.42%32.66M | -15.63%25.55M | -17.31%18.13M | 19.41%8.54M | 30.69%40.03M | 19.52%30.28M |
| -Interest Income (Financial expense) | 42.37%-2.63M | 33.19%-1.94M | 71.87%-1.1M | 72.64%-250.3K | 2.99%-4.56M | 13.81%-2.91M | -66.45%-3.93M | 3.04%-914.91K | -56.02%-4.7M | -2.05%-3.37M |
| Research and development | 62.79%11.92M | 36.99%6.87M | 23.02%3.86M | 15.98%1.72M | -82.70%7.32M | -87.65%5.02M | -85.85%3.14M | -85.09%1.48M | -14.44%42.32M | 41.99%40.62M |
| Credit Impairment Loss | -30.53%-149.24K | -14.66%-195.36K | -63.02%-92.98K | -262.99%-79.59K | -115.58%-114.34K | -128.72%-170.38K | -106.48%-57.04K | -94.38%48.83K | -73.85%733.65K | -91.25%593.29K |
| Asset Impairment Loss | -122.11%-5M | -656.40%-1.32M | -653.71%-1.32M | ---- | 62.04%-2.25M | 108.46%237.69K | 1,016.95%237.69K | 100.29%97.45 | -213.09%-5.93M | -276.20%-2.81M |
| Other net revenue | 281.19%115.95M | -246.19%-11.51M | 827.65%37.64M | 588.50%131.56M | -79.73%30.42M | -94.56%7.87M | -115.60%-5.17M | 14.81%19.11M | 31.19%150.05M | 103.84%144.63M |
| Fair value change income | 3,111.57%116M | 43.84%-17.56M | 178.92%24.55M | 20,311.02%131.93M | 94.86%-3.85M | ---31.27M | ---31.1M | --646.35K | ---74.94M | ---- |
| Invest income | -117.92%-4.84M | -88.44%3.22M | -56.84%10.05M | -152.55%-8.44M | -87.53%26.98M | -79.93%27.88M | -16.72%23.28M | 12.36%16.06M | 131.93%216.42M | 147.93%138.89M |
| -Including: Investment income associates | -469.81%-27.81M | -273.60%-16.04M | -287.90%-9M | -4,280.04%-5.19M | -92.72%7.52M | -73.31%9.24M | -76.43%4.79M | -101.27%-118.43K | 17.37%103.28M | -30.20%34.61M |
| Asset deal income | ---- | ---- | ---- | ---- | 692.68%35.95K | ---- | ---- | ---- | -105.82%-6.07K | ---- |
| Other revenue | 3.27%9.93M | -61.22%4.35M | 80.65%4.46M | 247.23%8.16M | -30.17%9.62M | 40.76%11.21M | -43.28%2.47M | 55.54%2.35M | -31.29%13.77M | 21.37%7.96M |
| Operating profit | 208.07%265.57M | -22.64%40.49M | 195.56%68.24M | 543.07%146.61M | -59.28%86.2M | -70.68%52.34M | -50.12%23.09M | 26.67%22.8M | -3.29%211.7M | 68.46%178.52M |
| Add:Non operating Income | -22.29%332.14K | -87.14%53.37K | -37.07%254.49K | -74.50%18.65K | -71.81%427.44K | -65.58%414.88K | -46.73%404.37K | -78.39%73.13K | -50.66%1.52M | -56.68%1.21M |
| Less:Non operating expense | 227.78%529.28K | 1,565.56%469.05K | 5,379.89%427.32K | ---- | -97.39%161.47K | -94.10%28.16K | -97.46%7.8K | -98.23%5.16K | 137.53%6.19M | 197.10%477.22K |
| Total profit | 206.90%265.37M | -24.00%40.07M | 189.83%68.07M | 541.24%146.63M | -58.23%86.47M | -70.58%52.73M | -49.75%23.49M | 26.71%22.87M | -5.63%207.03M | 65.06%179.25M |
| Less:Income tax cost | 373.14%27.6M | -1,046.45%-5.59M | 657.82%29.68M | 980.37%36.97M | -89.45%5.83M | -98.65%590.52K | -152.49%-5.32M | 40.05%3.42M | 166.77%55.3M | 252.15%43.77M |
| Net profit | 194.87%237.77M | -12.42%45.66M | 33.28%38.39M | 463.96%109.66M | -46.86%80.63M | -61.51%52.14M | -21.31%28.81M | 24.62%19.44M | -23.62%151.73M | 40.88%135.47M |
| Net profit from continuing operation | 194.87%237.77M | -12.42%45.66M | 33.28%38.39M | 463.96%109.66M | -46.86%80.63M | -61.51%52.14M | -21.31%28.81M | 24.62%19.44M | -23.62%151.73M | 40.88%135.47M |
| Less:Minority Profit | 1,124.84%81.23M | 31.62%9.41M | 26.90%8.4M | -78.77%1.01M | -20.03%6.63M | -38.95%7.15M | 164.25%6.62M | 198.32%4.77M | 46.06%8.29M | 199.52%11.71M |
| Net profit of parent company owners | 111.53%156.54M | -19.42%36.25M | 35.18%29.99M | 640.61%108.64M | -48.41%74M | -63.65%44.99M | -34.94%22.19M | 4.77%14.67M | -25.67%143.44M | 34.16%123.76M |
| Earning per share | ||||||||||
| Basic earning per share | 111.50%0.4541 | -19.39%0.1052 | 35.09%0.087 | 639.91%0.3152 | -48.40%0.2147 | -63.65%0.1305 | -34.88%0.0644 | 4.93%0.0426 | -25.67%0.4161 | 34.16%0.359 |
| Diluted earning per share | 111.50%0.4541 | -19.39%0.1052 | 35.09%0.087 | 639.91%0.3152 | -48.40%0.2147 | -63.65%0.1305 | -34.88%0.0644 | 4.93%0.0426 | -25.67%0.4161 | 34.16%0.359 |
| Other composite income | 42.35%318.48K | -115.34%-76.16K | -77.61%111.39K | 101.84%5.69K | -94.42%223.72K | -90.89%496.56K | -69.37%497.57K | -8.41%-308.7K | 392.44%4.01M | 401.71%5.45M |
| Other composite income of parent company owners | 42.35%318.48K | -115.34%-76.16K | -77.61%111.39K | 101.84%5.69K | -94.42%223.72K | -90.89%496.56K | -69.37%497.57K | -8.41%-308.7K | 392.44%4.01M | 401.71%5.45M |
| Total composite income | 194.45%238.09M | -13.39%45.59M | 31.39%38.5M | 473.09%109.66M | -48.08%80.86M | -62.65%52.63M | -23.35%29.3M | 24.93%19.14M | -21.06%155.74M | 49.36%140.93M |
| Total composite income of parent company owners | 111.32%156.86M | -20.46%36.18M | 32.70%30.1M | 656.57%108.65M | -49.66%74.23M | -64.80%45.48M | -36.51%22.68M | 4.69%14.36M | -23.05%147.45M | 42.87%129.22M |
| Total composite income of minority owners | 1,124.84%81.23M | 31.62%9.41M | 26.90%8.4M | -78.77%1.01M | -20.03%6.63M | -38.95%7.15M | 164.25%6.62M | 198.32%4.77M | 46.06%8.29M | 199.52%11.71M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
